# Shore Bancshares Inc: overview

SHBI · Nasdaq · CIK 1035092 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/shbi.md) · [Financials](/companies/shbi/financials.md) · [Filings](/companies/shbi/filings.md) · [Insiders](/companies/shbi/insiders.md)

Latest reported revenue: [$6.0m](/filings/0001035092-26-000046.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 3, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001035092-26-000046).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [4.7](/filings/0001035092-25-000022.md) | [6.2 d](/filings/0001035092-26-000014.md) | [4.8](/filings/0001035092-26-000030.md) | [5.8](/filings/0001035092-26-000046.md) | [5.1](/filings/0001035092-25-000022.md) | [5.4 d](/filings/0001035092-26-000014.md) | [5.4](/filings/0001035092-26-000030.md) | [6.0](/filings/0001035092-26-000046.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [236.1%](/filings/0001035092-25-000022.md) | [213.9% d](/filings/0001035092-26-000014.md) | [288.5%](/filings/0001035092-26-000046.md) | [267.5%](/filings/0001035092-26-000046.md) | [279.6%](/filings/0001035092-25-000022.md) | [295.6% d](/filings/0001035092-26-000014.md) | [317.1%](/filings/0001035092-26-000046.md) | [314.4%](/filings/0001035092-26-000046.md) |
| Diluted EPS | $ per share | [0.34](/filings/0001035092-25-000022.md) | not reported | [0.41](/filings/0001035092-26-000030.md) | [0.46](/filings/0001035092-26-000046.md) | [0.43](/filings/0001035092-25-000022.md) | not reported | [0.51](/filings/0001035092-26-000030.md) | [0.56](/filings/0001035092-26-000046.md) |
| Free cash flow | $m | [8.4 d](/filings/0001035092-25-000022.md) | [31.2 d](/filings/0001035092-26-000014.md) | [18.8](/filings/0001035092-26-000030.md) | [(9.2) d](/filings/0001035092-26-000046.md) | [41.9 d](/filings/0001035092-25-000022.md) | [7.8 d](/filings/0001035092-26-000014.md) | [30.5](/filings/0001035092-26-000030.md) | [7.0 d](/filings/0001035092-26-000046.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [11.0](/filings/0001558370-23-005139.md) | [15.3](/filings/0001628280-24-011336.md) | [18.3](/filings/0001035092-26-000014.md) | [20.9](/filings/0001035092-26-000014.md) | [20.9](/filings/0001035092-26-000014.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [139.6%](/filings/0001558370-23-005139.md) | [203.2%](/filings/0001628280-24-011336.md) | [61.2%](/filings/0001035092-26-000014.md) | [209.9%](/filings/0001035092-26-000014.md) | [285.4%](/filings/0001035092-26-000014.md) |
| Diluted EPS | $ per share | [1.17](/filings/0001558370-23-005139.md) | [1.57](/filings/0001628280-24-011336.md) | [0.42](/filings/0001035092-26-000014.md) | [1.32](/filings/0001035092-26-000014.md) | [1.78](/filings/0001035092-26-000014.md) |
| Free cash flow | $m | [(11.0)](/filings/0001558370-23-005139.md) | [50.2](/filings/0001628280-24-011336.md) | [16.8](/filings/0001035092-26-000014.md) | [41.7](/filings/0001035092-26-000014.md) | [59.2](/filings/0001035092-26-000014.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/shbi/insiders.md)

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-27 | [Lamon John](/insiders/1463254.md) | Director | Purchase (P) | 338 | $22.94 | $7.8k | [Form 4](/filings/0001463254-26-000008.md) |

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $73.8m | 3,215,010 |  | Added +191,443 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $40.7m | 1,774,718 |  | Added +91,315 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $30.9m | 1,345,267 |  | Reduced −31,267 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $25.2m | 1,095,951 |  | Added +135,343 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $23.6m | 1,029,202 |  | Added +104,039 |
| [MANUFACTURERS LIFE INSURANCE COMPANY, THE](/funds/928047.md) | 2026-06-30 | $20.3m | 885,021 |  | Reduced −5,063 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $18.7m | 816,475 |  | Added +47,534 |
| [WELLINGTON MANAGEMENT GROUP LLP](/funds/902219.md) | 2026-06-30 | $17.6m | 768,354 |  | Reduced −245,321 |
| [Jupiter Topco LLC](/funds/2146052.md) | 2026-06-30 | $17.1m | 745,516 |  | Not compared |
| [AMERIPRISE FINANCIAL INC](/funds/820027.md) | 2026-06-30 | $12.0m | 523,562 |  | Added +79,403 |

## Recent filings

[All 1,161 filings](/companies/shbi/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 14:52 ET | [8-K](/filings/0001035092-26-000060.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001035092-26-000060 |
| 2026-10-22 | 16:01 ET | [8-K](/filings/0001035092-26-000058.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001035092-26-000058 |
| 2026-10-01 | 11:35 ET | [8-K](/filings/0001035092-26-000054.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001035092-26-000054 |
| 2026-08-25 | 12:31 ET | [8-K](/filings/0001035092-26-000050.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001035092-26-000050 |
| 2026-08-03 | 15:32 ET | [10-Q](/filings/0001035092-26-000046.md) | Quarterly report, period 2026-06-30 | 0001035092-26-000046 |
| 2026-07-24 | 16:00 ET | [8-K](/filings/0001035092-26-000043.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001035092-26-000043 |
| 2026-07-23 | 16:11 ET | [8-K](/filings/0001035092-26-000041.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001035092-26-000041 |
| 2026-07-23 | 16:00 ET | [8-K](/filings/0001035092-26-000040.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001035092-26-000040 |
| 2026-06-16 | 08:00 ET | [8-K](/filings/0001035092-26-000037.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001035092-26-000037 |
| 2026-05-22 | 09:01 ET | [8-K](/filings/0001035092-26-000035.md) | 5.05 Item not in the standard list; 9.01 Financial statements and exhibits | 0001035092-26-000035 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001035092-26-000014.md), filed Mar 2, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1035092
- Tickers: SHBI
- Exchange: Nasdaq
- SIC code: 6021 National Commercial Banks
- State of incorporation: MD
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 11:26 ET. No prices; not investment advice.